Read + Share
Chwistek M, Sherry D, Kinczewski L, Silveira MJ, et al. Should Buprenorphine be considered a first-line opioid for the treatment of
moderate to severe cancer pain? J Pain Symptom Manage 2023 Jun 19:S0885-3924(23)00566.
PMID: 37343903
|
 |
|
Chwistek M, Sherry D, Kinczewski L, Silveira MJ, et al. Should Buprenorphine be considered a first-line opioid for the treatment of
moderate to severe cancer pain? J Pain Symptom Manage 2023 Jun 19:S0885-3924(23)00566.
PMID: 37343903
|
|
|
|